David Dai

Q: What is David Dai's success rate?

David Dai currently has a success rate of 81.7985119860983.

Q: What is the average return of David Dai's calls?

Their stock ratings have generated an average return of 17.5612858288135.

Bernstein | Healthcare

David Dai is an analyst from Bernstein specializing in the Healthcare sector. Ranked #1663 out of 4656 analysts, they have issued 22 stock ratings with a success rate of 81.80% and an average return of 17.56%.

David Dai has a well-established track record, with 22 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 81.80% and an average return of 17.56%, underscoring their expertise and ability to identify winning opportunities for investors.

#1663

Out of 4656

Total Ratings

+81.80%

Success Rate

+17.56%

Average Return

Recent Ratings Analysis

ARM

Buy

May 18, 2026

Target

$300.00

Current

$215.12

Performance

0.00%

David Dai rated ARM as Outperform on May 18, 2026, setting a price target of 300. Shares have remained stable near 215.12, leaving the 300 target still in play.

SNDX

Buy

May 13, 2026

Target

$37.00

Current

$19.41

Performance

-7.08%

On May 13, 2026, SNDX was given a Buy rating by David Dai, with a target price of 37. Despite the Buy call, shares fell from 19.41 to 19.41, challenging the optimistic stance.

JANX

Hold

Apr 15, 2026

Target

$15.00

Current

$14.03

Performance

—

JANX received a Neutral rating from David Dai on Apr 15, 2026, aiming for 15. Shares remained flat at 14.03, aligning with the neutral rating.

ASML

Buy

Mar 26, 2026

Target

$1971.00

Current

$1472.39

Performance

—

On Mar 26, 2026, David Dai published a Outperform outlook on ASML, with a target of 1971. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 1472.39.

JSPR

Hold

Mar 23, 2026

Target

$1.50

Current

$0.81

Performance

-32.23%

David Dai on Mar 23, 2026 assigned JSPR a Neutral rating, with a price target of 1.5. The call successfully avoided chasing as shares lost 32.23%.

CATX

Buy

Mar 18, 2026

Target

$8.00

Current

$3.76

Performance

-22.63%

On Mar 18, 2026, David Dai reaffirmed CATX with a Buy rating, targeting 8. Shares slid 22.63% despite the recommendation, highlighting downside risks.

SONY

Hold

Mar 17, 2026

Target

$22.00

Current

$22.71

Performance

8.56%

SONY was rated Market Perform by David Dai on Mar 17, 2026, with a price objective of 22. Despite caution, upside momentum rewarded risk-takers with gains to 22.71.

KURA

Buy

Mar 13, 2026

Target

$15.00

Current

$9.20

Performance

6.36%

On Mar 13, 2026, David Dai initiated coverage on KURA with a Buy rating and target of 15. The stock’s climb of 6.36% since the call highlights the foresight in the rating.

IOVA

Hold

Mar 05, 2026

Target

$4.00

Current

$3.39

Performance

—

David Dai issued a Neutral recommendation for IOVA on Mar 05, 2026, price target set at 4. The rating was appropriate for a consolidating market trading near 3.39.

KYMR

Buy

Mar 03, 2026

Target

$128.00

Current

$79.67

Performance

-7.74%

On Mar 03, 2026, KYMR was evaluated by David Dai, who gave a Buy rating and target of 128. Investors saw limited payoff as shares fell short of the 128 target.

BNTX

Hold

Nov 06, 2025

Target

$117.00

Current

$88.85

Performance

-14.03%

David Dai rated BNTX as Neutral on Nov 06, 2025, setting a price target of 117. The cautious Hold call aligned with subsequent weakness, as shares slipped 14.03%.

NUVL

Buy

Oct 31, 2025

Target

$132.00

Current

$99.90

Performance

0.58%

On Oct 31, 2025, NUVL was given a Buy rating by David Dai, with a target price of 132. The stock traded sideways with a 0.58% move, keeping the bullish thesis unresolved.

MRUS

Hold

Sep 30, 2025

Target

$97.00

Current

$90.00

Performance

-4.41%

MRUS received a Neutral rating from David Dai on Sep 30, 2025, aiming for 97. Shares remained flat at 90, aligning with the neutral rating.

TLX

Buy

Sep 23, 2025

Target

$20.00

Current

$10.28

Performance

-5.95%

On Sep 23, 2025, David Dai published a Buy outlook on TLX, with a target of 20. Market action contradicted the Buy thesis, as shares slipped to 10.28.

NRIX

Buy

Jul 10, 2025

Target

$26.00

Current

$15.51

Performance

22.42%

David Dai on Jul 10, 2025 assigned NRIX a Buy rating, with a price target of 26. The Buy call aligned well with market performance, producing a gain of 22.42%.

SMMT

Buy

Jul 01, 2025

Target

$30.00

Current

$16.02

Performance

-24.43%

On Jul 01, 2025, David Dai reaffirmed SMMT with a Buy rating, targeting 30. Shares slid 24.43% despite the recommendation, highlighting downside risks.

Frequency Asked Questions

Who is David Dai?

David Dai is an analyst from Bernstein specializing in the Healthcare sector.

What is David Dai's success rate?

David Dai currently has a success rate of +81.80%.

How many ratings has David Dai issued?

David Dai has issued 22 stock ratings so far.

What is the average return of David Dai's calls?

Their stock ratings have generated an average return of +17.56%.

What is David Dai's ranking?

David Dai is ranked #1663 out of 4656 analysts.

What types of ratings does David Dai give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow David Dai?

You can follow David Dai by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by David Dai?

Their latest rating was a Buy on ARM issued on 2026-05-18.